Related content

Assessment and Treatment Selection for “Revolving Door” Inpatients with Schizophrenia

By Weiden P.   Glazer W.  

Psychiatric Quarterly, Vol. 68, Iss. 4, 1997-01 ,pp. : 377-392

Springer Publishing Company

Access to resources Recommend Favorite

Schizophrenia

By  

International Review of Psychiatry, Vol. 9, Iss. 4, 1997-12 ,pp. : 317-320

Informa Healthcare

Access to resources Recommend Favorite

No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine

By Tsai S.-J.   Hong C.-J.   Yu Y.W.-Y.   Lin C.-H.   Liu L.-L.  

Schizophrenia Research, Vol. 65, Iss. 1, 2003-12 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia

By Molina V.   Reig S.   Sarramea F.   Sanz J.   Francisco Artaloytia J.   Luque R.   Aragues M.   Pascau J.   Benito C.   Palomo T.   Desco M.  

Psychiatry Research: Neuroimaging, Vol. 124, Iss. 3, 2003-11 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite

Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology

By Gervin M.   Browne S.   Garavan J.   Roe M.   Larkin C.   O'Callaghan E.  

European Psychiatry, Vol. 14, Iss. 7, 1999-11 ,pp. : 405-409

Elsevier

Access to resources Recommend Favorite